Clinical Trial Update: Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial comparing aripiprazole (Abilify) to placebo in children with subsyndromal bipolar disorder has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-05-05